Screening for diabetic retinopathy

Published

Book Section

Screening is worthwhile when certain criteria are met: a disease has public health importance; an effective treatment exists; an interval exists within which treatment can effect benefit; and the disease is neither too rare nor too common.1 Screening for diabetes mellitus in those over 40 years of age and screening for diabetic retinopathy (DR) in those with known diabetes mellitus fulfill these criteria.2,3 Beyond improving health-related outcomes, treatment of diabetes and DR is cost effective.4,5,6 Thus, the value of screening for DR is widely recognized. There is, however, controversy regarding the best screening method and screening intervals. 7 © 2010 Springer-Verlag New York.

Full Text

Duke Authors

Cited Authors

  • Browning, DJ

Published Date

  • December 1, 2010

Book Title

  • Diabetic Retinopathy: Evidence-Based Management

Start / End Page

  • 369 - 385

International Standard Book Number 13 (ISBN-13)

  • 9780387858999

Digital Object Identifier (DOI)

  • 10.1007/978-0-387-85900-2-14

Citation Source

  • Scopus